Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686

被引:2
|
作者
Ou, Horng-Yih [1 ]
Karnchanasorn, Rudruidee [2 ]
Chuang, Lee-Ming [3 ,4 ]
Chiu, Ken C. [5 ,6 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med,Div Endocrinol & Metab, Tainan 70101, Taiwan
[2] Univ Kansas, Med Ctr, Dept Internal Med, Div Endocrinol Metab & Genet, Kansas City, KS 66103 USA
[3] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan
[4] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Prevent Med, Taipei 10764, Taiwan
[5] City Hope Natl Med Ctr, Dept Diabet Endocrinol & Metab, Duarte, CA 86294 USA
[6] Harbor UCLA Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Torrance, CA 90509 USA
关键词
D O I
10.2337/dc15-1700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E198 / E198
页数:1
相关论文
共 50 条
  • [1] Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program. Diabetes Care 2015;38:1680-1686
    Dhatariya, Ketan
    [J]. DIABETES CARE, 2016, 39 (01) : E18 - E18
  • [2] Diabetic Ketoacidosis and Related Events in the Canagliflozin Type 2 Diabetes Clinical Program
    Erondu, Ngozi
    Desai, Mehul
    Ways, Kirk
    Meininger, Gary
    [J]. DIABETES CARE, 2015, 38 (09) : 1680 - 1686
  • [3] Diabetic ketoacidosis in type 2 diabetes mellitus—pathophysiology and clinical presentation
    Stephen N Davis
    Guillermo E Umpierrez
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 730 - 731
  • [4] Diabetic ketoacidosis in type 2 diabetes mellitus - pathophysiology and clinical presentation
    Davis, Stephen N.
    Umpierrez, Guillermo E.
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (11): : 730 - 731
  • [5] Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes
    Peters, Anne L.
    Henry, Robert R.
    Thakkar, Payal
    Tong, Cindy
    Alba, Maria
    [J]. DIABETES CARE, 2016, 39 (04) : 532 - 538
  • [6] The Diabetes Shared Care Program and Risks of Cardiovascular Events in Type 2 Diabetes
    Kornelius, Edy
    Chiou, Jeng-Yuan
    Yang, Yi-Sun
    Lu, Ying-Li
    Peng, Chiung-Huei
    Huang, Chien-Ning
    [J]. AMERICAN JOURNAL OF MEDICINE, 2015, 128 (09): : 977 - +
  • [7] Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus -: clinical and biochemical differences
    Saranovic, L.
    Krdzalic, N.
    [J]. MEDICINSKI GLASNIK, 2007, 4 (01) : 39 - 43
  • [8] Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus - Clinical and biochemical differences
    Newton, CA
    Raskin, P
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (17) : 1925 - 1931
  • [9] Severe diabetic ketoacidosis, acute kidney injury and dehydration due to canagliflozin in type 2 diabetes mellitus patient: Atypical clinical presentation
    Moreno Obregon, Fernando
    Espino Montoro, Antonio
    Marin Martin, Jorge
    Leon Jimenez, David
    [J]. ATENCION PRIMARIA, 2019, 51 (10): : 664 - 666
  • [10] RAPID ONSET OF EUGLYCEMIC DIABETIC KETOACIDOSIS DUE TO CANAGLIFLOZIN IN A CASE OF NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
    Gyawali, B.
    Martinez, F.
    Martinez-Balzano, C.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 401 - 402